Activation of NF-κB drives the enhanced survival of adipose tissue macrophages in an obesogenic environment

Molecular Metabolism

Volumn 4, Issue 10, 2015, Pages 665-677

  Hill, Andrea A ^a   Anderson Baucum, Emily K ^a,c   Kennedy, Arion J ^a   Webb, Corey D ^a   Yull, Fiona E ^a   Hasty, Alyssa H ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose tissue; Apoptosis; Cleaved caspase 3; Macrophage; NF B; Survival

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HUMAN; INSULIN RESISTANCE; MACROPHAGE; MITOCHONDRION; MONOCYTE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION;

EID: 84942198990     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.07.005     Document Type: Article

References (66)

1. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003, 112:1796-1808.
2. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003, 112:1821-1830.
3. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine 2009, 15:930-939.
4. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis Thrombosis and Vascular Biology 2008, 28:1304-1310.
5. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nature Medicine 2009, 15:914-920.
6. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nature Medicine 2009, 15:921-929.
7. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nature Medicine 2011, 17:610-617.
8. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
9. Elgazar-Carmon V., Rudich A., Hadad N., Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. Journal of Lipid Research 2008, 49:1894-1903.
10. Choi S.H., Hong E.S., Lim S. Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. Front Endocrinol (Lausanne) 2013, 4:97.
11. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annual Review of Physiology 2010, 72:219-246.
12. Huber J., Kiefer F.W., Zeyda M., Ludvik B., Silberhumer G.R., Prager G., et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. The Journal of Clinical Endocrinology and Metabolism 2008, 93:3215-3221.
13. Lumeng C.N., DelProposto J.B., Westcott D.J., Saltiel A.R. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008, 57:3239-3246.
14. Inouye K.E., Shi H., Howard J.K., Daly C.H., Lord G.M., Rollins B.J., et al. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 2007, 56:2242-2250.
15. Kennedy A., Webb C.D., Hill A.A., Gruen M.L., Jackson L.G., Hasty A.H. Loss of CCR5 results in glucose intolerance in diet-induced obese mice. American Journal of Physiology. Endocrinology and Metabolism 2013, 305:E897-E906.
16. Kirk E.A., Sagawa Z.K., McDonald T.O., O'Brien K.D., Heinecke J.W. Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes 2008, 57:1254-1261.
17. Morris D.L., Oatmen K.E., Wang T., DelProposto J.L., Lumeng C.N. CX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity. Obesity 2012, 20:1189-1199.
18. Surmi B.K., Webb C.D., Ristau A.C., Hasty A.H. Absence of macrophage inflammatory protein-1{alpha} does not impact macrophage accumulation in adipose tissue of diet-induced obese mice. American Journal of Physiology. Endocrinology and Metabolism 2010, 299:E437-E445.
19. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. Journal of Clinical Investigation 2006, 116:1494-1505.
20. Nara N., Nakayama Y., Okamoto S., Tamura H., Kiyono M., Muraoka M., et al. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. The Journal of Biological Chemistry 2007, 282:30794-30803.
21. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation 2006, 116:115-124.
22. Tamura Y., Sugimoto M., Murayama T., Ueda Y., Kanamori H., Ono K., et al. Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28:2195-2201.
23. Ito A., Suganami T., Yamauchi A., Degawa-Yamauchi M., Tanaka M., Kouyama R., et al. Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. The Journal of Biological Chemistry 2008, 283:35715-35723.
24. Westcott D.J., Delproposto J.B., Geletka L.M., Wang T., Singer K., Saltiel A.R., et al. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. The Journal of Experimental Medicine 2009, 206:3143-3156.
25. Amano S.U., Cohen J.L., Vangala P., Tencerova M., Nicoloro S.M., Yawe J.C., et al. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metabolism 2014, 19:162-171.
26. Haase J., Weyer U., Immig K., Kloting N., Bluher M., Eilers J., et al. Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia 2014, 57:562-571.
27. Ramkhelawon B., Hennessy E.J., Menager M., Ray T.D., Sheedy F.J., Hutchison S., et al. Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. Nature Medicine 2014, 20:377-384.
28. Curtin J.F., Cotter T.G. Apoptosis: historical perspectives. Essays in Biochemistry 2003, 39:1-10.
29. Elmore S. Apoptosis: a review of programmed cell death. Toxicologic Pathology 2007, 35:495-516.
30. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nature Reviews Molecular Cell Biology 2008, 9:47-59.
31. Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harbor Perspectives in Biology 2009, 1:a000141.
32. Hoesel B., Schmid J.A. The complexity of NF-kappaB signaling in inflammation and cancer. Molecular Cancer 2013, 12:86.
33. Chiang S.H., Bazuine M., Lumeng C.N., Geletka L.M., Mowers J., White N.M., et al. The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 2009, 138:961-975.
34. Everhart M.B., Han W., Sherrill T.P., Arutiunov M., Polosukhin V.V., Burke J.R., et al. Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. Journal of Immunology 2006, 176:4995-5005.
35. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001, 29:e45.
36. Altintas M.M., Rossetti M.A., Nayer B., Puig A., Zagallo P., Ortega L.M., et al. Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids in Health and Disease 2011, 10:198.
37. Meher A.K., Sharma P.R., Lira V.A., Yamamoto M., Kensler T.W., Yan Z., et al. Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance. Free Radical Biology & Medicine 2012, 52:1708-1715.
38. Murano I., Barbatelli G., Parisani V., Latini C., Muzzonigro G., Castellucci M., et al. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. Journal of Lipid Research 2008, 49:1562-1568.
39. Kratz M., Coats B.R., Hisert K.B., Hagman D., Mutskov V., Peris E., et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metabolism 2014, 20:614-625.
40. Grubbs F. Procedures for detecting outlying observations in samples. Technometrics 1969, 11:1-21.
41. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research 2005, 46:2347-2355.
42. Alkhouri N., Gornicka A., Berk M.P., Thapaliya S., Dixon L.J., Kashyap S., et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. The Journal of Biological Chemistry 2010, 285:3428-3438.
43. Chipuk J.E., Moldoveanu T., Llambi F., Parsons M.J., Green D.R. The BCL-2 family reunion. Molecular Cell 2010, 37:299-310.
44. Lindsay J., Esposti M.D., Gilmore A.P. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochimica et Biophysica Acta 2011, 1813:532-539.
45. Chen C., Edelstein L.C., Gelinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Molecular Cell Biology 2000, 20:2687-2695.
46. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nature Immunology 2012, 13:1118-1128.
47. Burke J.R., Pattoli M.A., Gregor K.R., Brassil P.J., MacMaster J.F., McIntyre K.W., et al. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. The Journal of Biological Chemistry 2003, 278:1450-1456.
48. Gutierrez D.A., Kennedy A., Orr J.S., Anderson E.K., Webb C.D., Gerrald W.K., et al. Aberrant accumulation of undifferentiated myeloid cells in the adipose tissue of CCR2-deficient mice delays improvements in insulin sensitivity. Diabetes 2011, 60:2820-2829.
49. Tsou C.L., Peters W., Si Y., Slaymaker S., Aslanian A.M., Weisberg S.P., et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. Journal of Clinical Investigation 2007, 117:902-909.
50. Gericke M., Weyer U., Braune J., Bechmann I., Eilers J. A method for long-term live-imaging of tissue macrophages in adipose tissue explants. American Journal of Physiology, Endocrinology and Metabolism 2015, ajpendo 00075 02015.
51. Haghiac M., Vora N.L., Basu S., Johnson K.L., Presley L., Bianchi D.W., et al. Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity 2012, 20:2213-2219.
52. Feng B., Jiao P., Nie Y., Kim T., Jun D., van Rooijen N., et al. Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice. PloS One 2011, 6:e24358.
53. Bodles A.M., Varma V., Yao-Borengasser A., Phanavanh B., Peterson C.A., McGehee R.E., et al. Pioglitazone induces apoptosis of macrophages in human adipose tissue. Journal of Lipid Research 2006, 47:2080-2088.
54. Di Gregorio G.B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L.M., et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005, 54:2305-2313.
55. Gao Z., Zhang J., Henagan T.M., Lee J.H., Ye X., Wang H., et al. P65 inactivation in adipocytes and macrophages attenuates adipose inflammatory response in lean but not in obese mice. American Journal of Physiology. Endocrinology and metabolism 2015, 308:E496-E505.
56. Cai Y., Sugimoto C., Arainga M., Alvarez X., Didier E.S., Kuroda M.J. In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: implications for understanding lung disease in humans. Journal of Immunology 2014, 192:2821-2829.
57. Hashimoto D., Chow A., Noizat C., Teo P., Beasley M.B., Leboeuf M., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013, 38:792-804.
58. Arai S., Shelton J.M., Chen M., Bradley M.N., Castrillo A., Bookout A.L., et al. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metabolism 2005, 1:201-213.
59. Liu J., Thewke D.P., Su Y.R., Linton M.F., Fazio S., Sinensky M.S. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25:174-179.
60. Tabas I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death and Differentiation 2004, 11(Suppl 1):S12-S16.
61. Woo C.W., Cui D., Arellano J., Dorweiler B., Harding H., Fitzgerald K.A., et al. Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nature Cell Biology 2009, 11:1473-1480.
62. Yang J., Amiri K.I., Burke J.R., Schmid J.A., Richmond A. BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways. Clinical Cancer Research 2006, 12:950-960.
63. Scarlatti F., Granata R., Meijer A.J., Codogno P. Does autophagy have a license to kill mammalian cells?. Cell Death Differentiation 2009, 16:12-20.
64. Niture S.K., Jaiswal A.K. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance. Free Radical Biology and Medicine 2013, 57:119-131.
65. Niture S.K., Jaiswal A.K. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. The Journal of Biological Chemistry 2012, 287:9873-9886.
66. Pi J., Leung L., Xue P., Wang W., Hou Y., Liu D., et al. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. The Journal of Biological Chemistry 2010, 285:9292-9300.